DELPHX ANNOUNCES CLOSING OF NON-BROKERED UNIT PRIVATE PLACEMENT

Rhea-AI Summary

DelphX Capital Markets (OTCQB: DPXCF) closed a non-brokered unit private placement on April 29, 2026, issuing 3,000,000 units at C$0.04 per unit for gross proceeds of C$120,000. Each unit includes one common share and one warrant exercisable at $0.08 for two years.

Securities are subject to TSXV approval and a four-month plus one-day hold. Net proceeds are intended for working capital and corporate overhead.

AI-generated analysis. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Toronto, Ontario, April 29, 2026 (GLOBE NEWSWIRE) -- DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF) (“DelphX”), a leader in the development of new classes of structured products, announces that it has closed its non-brokered private placement previously announced on April 22, 2026 issuing 3,000,000 units (the “Units”) at a subscription price of C$0.04 per Unit, for gross proceeds of C$120,000 (“the Offering”). Each Unit consists of one common share (“Common Share”) and one Common Share purchase warrant (“Warrant”). Each Warrant entitles the holder to purchase one Common Share at a price of $0.08, for a period of two years from the date of issuance.

Completion of the Offering is subject to the approval of the TSX Venture Exchange. The securities issued pursuant to the Offering will be subject to a hold period of four months plus one day from the date of issuance.

DelphX intends to use the net proceeds from the Offering in connection with working capital/corporate overhead.

About DelphX Capital Markets Inc.

DelphX is a technology and financial services company focused on developing and distributing the next generation of structured products. Through its special purpose vehicle Quantem LLC, the Company enables broker dealers to offer new private placement securities that provide for both fixed income and cryptocurrency solutions. The new DelphX securities will enable dealers and their qualified institutional investors (QIBs) accounts to competitively structure, sell and make markets in:

• Collateralized put options (CPOs) that provide secured rating downgrade protection for underlying corporate bonds and/or protection from losses in cryptocurrency holdings;

• Collateralized reference notes (CRNs) that enable investors to take on a capped rating downgrade and/or cryptocurrency loss exposure of an underlying security or cryptocurrency in exchange for attractive returns.

All CPOs and CRNs are fully collateralized and held in custody by US Bank. CPOs and CRNs are proprietary products created and owned by DelphX Capital Markets.

For more information about DelphX, please visit www.delphx.com

George Wentworth, General Manager
DelphX Capital Markets Inc.
george.wentworth@delphx.com
(718) 509-2160

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
               

FAQ

What did DelphX (OTCQB: DPXCF) announce on April 29, 2026 about a private placement?

DelphX closed a non-brokered unit private placement issuing 3,000,000 units for gross proceeds of C$120,000. According to the company, each unit includes one common share and one two-year warrant exercisable at $0.08 per share.

How many warrants were issued in DelphX's April 29, 2026 financing and what are the terms?

Each of the 3,000,000 units included one warrant, so 3,000,000 warrants were issued in the financing. According to the company, each warrant is exercisable at $0.08 per common share for two years from issuance.

What will DelphX (DPXCF) use the net proceeds from the C$120,000 offering for?

DelphX intends to use the net proceeds for working capital and corporate overhead. According to the company, the funds are allocated to general corporate purposes rather than a specific project or acquisition.

Are the securities from DelphX's April 29, 2026 private placement subject to resale restrictions?

Yes, the securities are subject to a hold period of four months plus one day from the date of issuance. According to the company, completion remains subject to approval by the TSX Venture Exchange.

Does DelphX's private placement require regulatory approval and which exchange is involved?

Completion of the offering is subject to approval by the TSX Venture Exchange. According to the company, the TSXV must approve the issuance before the financing is fully completed and trading restrictions remain in place.